EXHIBITION PREVIEW Culture Collections (UKHSA).


contributions during the Zika outbreak and the COVID-19 pandemic. Culture Collections additionally


provides highquality, authenticated nucleic acids in multiple formats. These support a wide range of research and diagnostic applications, from vaccine development and therapeutic target identification to use as gene controls in PCR assays. By ensuring authenticity and consistency, Culture Collections enables robust, reproducible and meaningful scientific outcomes. www.culturecollections.org.uk


Don Whitley Scientific This year Don Whitley Scientific (DWS) is celebrating its 50th anniversary, while continuing to drive innovation with the upcoming launch of its next generation of Whitley Workstations. World-renowned for creating precise, fully customisable environments, these workstations support a wide range of microbiology and cell culture applications across research, clinical and industrial laboratories. Alongside the core product range,


DWS has expanded its portfolio to offer complementary solutions that support environmental control and sample integrity. The firm is now a distributor of Dickson’s OCEAView temperature monitoring systems, enabling continuous monitoring and recording of temperature,


Don Whitley Scientific.


humidity and CO₂ via an intuitive web and mobile platform. Whether safeguarding critical research, maintaining sensitive storage conditions or ensuring regulatory compliance, OCEAView provides a reliable and efficient solution. DWS is also an authorised distributor of COPAN, supplying a range


of automated laboratory solutions and advanced sample collection devices. The offering includes COPAN’s Liquid Based Microbiology solutions, such as eSwab, eNAT and Swab Rinse Kits. Featuring unique FLOQ technology in a variety of sizes, these devices deliver superior sample collection and elution efficiency. They are validated for use across multiple applications, including rapid antigen testing, EIA, PCR and other molecular assays, DFA and cytology testing, as well as bacteriology and virology. www.dwscientific.com


ELITech Group ELITech Molecular Diagnostics, part of the Bruker Corporation, delivers innovative sample-to-result solutions that advance infectious disease testing and precision diagnostics. The unparalleled – and continually expanding – assay menu, combined with platform flexibility, has driven adoption of the fully automated ELITe InGenius and ELITe BeGenius (pictured) systems across a broad range of clinical laboratories seeking efficient and versatile molecular testing. These platforms, together with


ELITech’s extensive portfolio of infectious disease and genetics assays, wide range of validated sample matrices, and flexible operating modes, integrate seamlessly into routine laboratory workflows. Recognised


ELITech Group.


for quality, reliability, and laboratory focused innovation, ELITech delivers robust molecular solutions that accelerate clinical decision making across virology, transplant monitoring, and broader infectious disease management. Visit the stand at this year’s BSMT


meeting, or reach out via the website to discuss your laboratory’s needs and explore how a tailored ELITech solution could support your workflow. www.elitechgroup.com/molecular- diagnostics-intl/


Genetic Signatures Genetic Signatures EasyScreen Pan- Enteric Detection Kit and automated workflow enables single-step sample processing and PCR set up for detection of 24 viral, bacterial and parasite gastrointestinal pathogens in a single test. These clinically relevant pathogen targets align with the S7 Gastroenteritis Syndromic Guidelines. Value driven solutions are delivered


by improved laboratory workflow with reduced hands-on time and improved ease-of-use. The workflow supports up to 42 samples per run or 84 samples in an eight-hour shift (up to 2,016 results). User- friendly, innovative results interpretation software also allows auto-validation and release of negative results, further improving the time to result. The EasyScreen Pan-Enteric Detection


Genetic Signatures. 46 WWW.PATHOLOGYINPRACTICE.COM April 2026


Kit’s enables a single ‘test’ for all samples from in-patient or GP services to support infection control efforts and contribute to effective disease surveillance. Genetic Signatures’ diagnostic assays are underpinned by proprietary 3base® technology which reduces the genetic complexity of detecting pathogens to improve multiplex PCR efficiency. www.geneticsignatures.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56